Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMIG4.L Regulatory News (MIG4)

  • There is currently no data for MIG4

Interim Management Statement

11 Nov 2014 14:08

RNS Number : 7294W
Mobeus Income & Growth 4 VCT PLC
11 November 2014
 



Mobeus Income & Growth 4 VCT plc (the Company)

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 September 2014

 

In accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UK Listing Authority, Mobeus Income & Growth 4 VCT plc presents an Interim Management Statement for the quarter ended 30 September 2014. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

NET ASSET VALUE (NAV) AND TOTAL RETURN PER SHARE

At 30 September 2014

At 30 June 2014

Net assets attributable to shareholders

£48,468,302

£52,878,546

Shares in issue

42,690,195

41,872,204

Net asset value (NAV) per share

113.53*p

126.29p

Cumulative dividends paid

52.20 p

38.20 p

Total return (net asset value basis) per share since inception

165.73p

164.49p

 

\* The fall in the NAV per share of 12.96 pence is mainly due above to the payment of the interim dividend of 14.00 pence per share, detailed below.

 

CUMULATIVE DIVIDENDS

 

The Company paid an interim dividend of 14.00 pence per share (comprising 12.00 pence from capital and 2.00 pence from income) on 12 September 2014, bringing cumulative dividends paid per share to date to 52.20 pence.

 

NEW INVESTMENT

 

In July 2014, the Company completed a new investment of £1.16 million to support the MBO of Tharstern Limited, the UK's leading supplier of software-based management information systems to the print sector.

 

DIVESTMENTS

 

The VCT completed the full realisation of its investment in DiGiCo Global Limited in July 2014 through a sale to a new professional audio group backed by Electra Partners, generating net cash proceeds of £1.73 million. The total proceeds received by the VCT over the life of this investment of £5.49 million represent a return on investment of 5.49 times original cost of £1.00 million.

 

Following the period-end, the VCT has realised its investments in Focus Pharma Holdings Limited and Youngman Group Limited for net cash proceeds of £1.53 million and £0.81 million respectively. The Company received total proceeds over the life of its investment in

Focus of £2.88 million, representing a return of 3.74 times original cost of £0.77 million. Similarly, over the life of the investment in Youngman, total proceeds of £1.21 million were generated, representing a return of 2.42 times original cost of £0.50 million

 

LOAN STOCK REPAYMENTS

 

A total of £0.15 million has been received in loan stock repayments during the quarter to 30 September 2014, including payments from Tessella Holdings Limited, Westway Services Holdings (2010) Limited and Virgin Wines Holding Company Limited. 

 

A further £0.05 million was received from Fullfield Limited (Motorclean) and Tharstern Limited following the period-end.

 

SHARE BUY-BACKS

 

The Company did not buy back any of its own shares during the quarter ended 30 September 2014. After the period, on 1 October 2014, 110,000 shares were bought back for cancellation. Following this repurchase of shares, there were 42,580,195 Ordinary shares in issue.

 

FUNDRAISING

 

The Company has announced its intention to launch an offer for subscription later this year to raise up to £6 million.

 

The offer will be promoted by Mobeus Equity Partners LLP, the investment adviser to the Company, and will be made alongside similar offers from Mobeus Income & Growth VCT plc, Mobeus Income & Growth 2 VCT plc and The Income & Growth VCT plc.

 

 

For further information, please contact:

Jonathan McGuire, for Mobeus Equity Partners LLP, Company Secretary: 020 7024 7600.

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSZFLFFZFFBFBQ
Date   Source Headline
26th Jul 20242:00 pmRNSGENERAL MEETINGS AND MERGER RESULTS
26th Jul 20247:30 amRNSSUSPENSION OF LISTING
24th Jul 20244:15 pmRNSNet Asset Value(s)
18th Jul 20241:31 pmRNSMERGER UPDATE AND GENERAL MEETINGS
4th Jul 20247:00 amRNSTransaction in Own shares and Total Voting Rights
1st Jul 20249:43 amRNSTotal Voting Rights and Capital
18th Jun 20246:01 pmRNSPROPOSED MERGER AND OFFERS
3rd Jun 20247:00 amRNSTotal Voting Rights and Capital
28th May 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
20th May 20245:37 pmRNSResult of Annual General Meeting
20th May 20247:00 amRNSInterim Management Statement
1st May 20247:00 amRNSTotal Voting Rights and Capital
26th Apr 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Apr 20247:00 amRNSAnnual Financial Report
2nd Apr 20249:30 amRNSTotal Voting Rights and Capital
22nd Mar 202410:02 amRNSDirector/PDMR Shareholding
22nd Mar 202410:00 amRNSIssue of Equity and Total Voting Rights
1st Mar 202411:00 amRNSTotal Voting Rights and Capital
28th Feb 20243:30 pmRNSMerger Discussions
27th Feb 20242:00 pmRNSRealisation of Investment: Master Removers Group
22nd Feb 202411:00 amRNSNet Asset Value(s)
6th Feb 20243:00 pmRNSDividend Declaration
1st Feb 202411:44 amRNSVoting Rights and Capital
2nd Jan 20241:00 pmRNSVoting Rights and Capital
21st Dec 202310:00 amRNSTransaction in Own Shares
1st Dec 20237:00 amRNSTotal Voting Rights
27th Nov 20237:00 amRNSTransaction in Own Shares
16th Nov 20232:00 pmRNSInterim Management Statement - replacement
15th Nov 20233:00 pmRNSInterim Management Statement
8th Nov 202310:35 amRNSDirector/PDMR Shareholding
8th Nov 202310:30 amRNSIssue of Equity and Total Voting Rights
1st Nov 20237:00 amRNSTotal Voting Rights
18th Oct 202310:00 amRNSTransaction in Own Shares
12th Oct 20237:00 amRNSStatement re Change of Registrar
5th Oct 20237:00 amRNSDividend Declaration
2nd Oct 20237:00 amRNSTotal Voting Rights
27th Sep 20237:00 amRNSHalf-year Report
22nd Sep 20237:00 amRNSDirector Declaration
1st Sep 20237:00 amRNSTotal Voting Rights
1st Aug 20237:00 amRNSTotal Voting Rights
26th Jul 20232:30 pmRNSInvestment Adviser Co-investment Incentive Scheme
3rd Jul 20237:00 amRNSTotal Voting Rights
28th Jun 202312:00 pmRNSTransaction in Own Shares
1st Jun 20237:00 amRNSTotal Voting Rights
26th May 20232:24 pmRNSDirector/PDMR Shareholding
26th May 202312:57 pmRNSIssue of Equity and Total Voting Rights
25th May 20237:00 amRNSResult of AGM
23rd May 20237:00 amRNSInterim Management Statement
2nd May 202310:00 amRNSTotal Voting Rights
19th Apr 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.